University of Hertfordshire

From the same journal

By the same authors

Standard

Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1 : Evaluation of in vitro clotting efficacy in the presence of certain contaminants. / Hall, Charlotte A.; Lydon, Helen L.; Dalton, Christopher H.; Chipman, J. Kevin; Graham, John S.; Chilcott, Robert.

In: Journal of Applied Toxicology, Vol. 35, No. 5, 01.05.2015, p. 536-542.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{034cc3cda7c941d78fc5c193e8230cad,
title = "Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1: Evaluation of in vitro clotting efficacy in the presence of certain contaminants",
abstract = "The treatment of penetrating, haemorrhaging injuries sustained within a hazardous environment may be complicated by contamination with toxic chemicals. There are currently no specific medical countermeasures for such injuries. Haemostats with an absorbent mechanism of action have the potential to simultaneously stop bleeding and decontaminate wounds. However, a primary requirement of a 'haemostatic decontaminant' is the retention of clotting function in the presence of chemical contaminants. Thus, the aim of this study was to investigate the haemostatic efficacy of seven commercially available haemostats in the presence of toxic chemicals (soman, VX, sulphur mustard, petrol, aviation fuel and motor oil). Clot viscosity was assessed ex vivo using thrombelastography following treatment of pig blood with: (i) toxic chemical; (ii) haemostat; or (iii) haemostat in combination with toxic chemical. Several contaminants (VX, petrol and GD) were found to be pro-haemostatic and none had an adverse effect on the rate with which the test products attained haemostasis. However, the total clot strength for blood treated with certain haemostats in the presence of sulphur mustard, soman and petrol was significantly decreased. Three test products failed to demonstrate haemostatic function in this ex vivo (thrombelastography) model; this was tentatively ascribed to the products achieving haemostasis through a tamponade mechanism of action, which can only be replicated using in vivo models. Overall, this study has identified a number of commercial products that may have potential as haemostatic decontaminants and warrant further investigation to establish their decontaminant efficacy. Copyright {\circledC} 2014 John Wiley & Sons, Ltd.",
keywords = "thrombelastography, toxic industrial chemicals, chemical warfare agents, haemostasis, decontamination",
author = "Hall, {Charlotte A.} and Lydon, {Helen L.} and Dalton, {Christopher H.} and Chipman, {J. Kevin} and Graham, {John S.} and Robert Chilcott",
note = "Charlotte A. Hall, et al, 'Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1: Evaluation of in vitro clotting efficacy in teh presence of certain contaminants', vol. 35 (5): 536-542, May 2015, doi: 10.1002/jat.3019. Copyright {\circledC} 2014 John Wiley & Sons, Ltd.",
year = "2015",
month = "5",
day = "1",
doi = "10.1002/jat.3019",
language = "English",
volume = "35",
pages = "536--542",
journal = "Journal of Applied Toxicology",
issn = "0260-437X",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

RIS

TY - JOUR

T1 - Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1

T2 - Evaluation of in vitro clotting efficacy in the presence of certain contaminants

AU - Hall, Charlotte A.

AU - Lydon, Helen L.

AU - Dalton, Christopher H.

AU - Chipman, J. Kevin

AU - Graham, John S.

AU - Chilcott, Robert

N1 - Charlotte A. Hall, et al, 'Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1: Evaluation of in vitro clotting efficacy in teh presence of certain contaminants', vol. 35 (5): 536-542, May 2015, doi: 10.1002/jat.3019. Copyright © 2014 John Wiley & Sons, Ltd.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The treatment of penetrating, haemorrhaging injuries sustained within a hazardous environment may be complicated by contamination with toxic chemicals. There are currently no specific medical countermeasures for such injuries. Haemostats with an absorbent mechanism of action have the potential to simultaneously stop bleeding and decontaminate wounds. However, a primary requirement of a 'haemostatic decontaminant' is the retention of clotting function in the presence of chemical contaminants. Thus, the aim of this study was to investigate the haemostatic efficacy of seven commercially available haemostats in the presence of toxic chemicals (soman, VX, sulphur mustard, petrol, aviation fuel and motor oil). Clot viscosity was assessed ex vivo using thrombelastography following treatment of pig blood with: (i) toxic chemical; (ii) haemostat; or (iii) haemostat in combination with toxic chemical. Several contaminants (VX, petrol and GD) were found to be pro-haemostatic and none had an adverse effect on the rate with which the test products attained haemostasis. However, the total clot strength for blood treated with certain haemostats in the presence of sulphur mustard, soman and petrol was significantly decreased. Three test products failed to demonstrate haemostatic function in this ex vivo (thrombelastography) model; this was tentatively ascribed to the products achieving haemostasis through a tamponade mechanism of action, which can only be replicated using in vivo models. Overall, this study has identified a number of commercial products that may have potential as haemostatic decontaminants and warrant further investigation to establish their decontaminant efficacy. Copyright © 2014 John Wiley & Sons, Ltd.

AB - The treatment of penetrating, haemorrhaging injuries sustained within a hazardous environment may be complicated by contamination with toxic chemicals. There are currently no specific medical countermeasures for such injuries. Haemostats with an absorbent mechanism of action have the potential to simultaneously stop bleeding and decontaminate wounds. However, a primary requirement of a 'haemostatic decontaminant' is the retention of clotting function in the presence of chemical contaminants. Thus, the aim of this study was to investigate the haemostatic efficacy of seven commercially available haemostats in the presence of toxic chemicals (soman, VX, sulphur mustard, petrol, aviation fuel and motor oil). Clot viscosity was assessed ex vivo using thrombelastography following treatment of pig blood with: (i) toxic chemical; (ii) haemostat; or (iii) haemostat in combination with toxic chemical. Several contaminants (VX, petrol and GD) were found to be pro-haemostatic and none had an adverse effect on the rate with which the test products attained haemostasis. However, the total clot strength for blood treated with certain haemostats in the presence of sulphur mustard, soman and petrol was significantly decreased. Three test products failed to demonstrate haemostatic function in this ex vivo (thrombelastography) model; this was tentatively ascribed to the products achieving haemostasis through a tamponade mechanism of action, which can only be replicated using in vivo models. Overall, this study has identified a number of commercial products that may have potential as haemostatic decontaminants and warrant further investigation to establish their decontaminant efficacy. Copyright © 2014 John Wiley & Sons, Ltd.

KW - thrombelastography

KW - toxic industrial chemicals

KW - chemical warfare agents

KW - haemostasis

KW - decontamination

U2 - 10.1002/jat.3019

DO - 10.1002/jat.3019

M3 - Article

C2 - 25131713

VL - 35

SP - 536

EP - 542

JO - Journal of Applied Toxicology

JF - Journal of Applied Toxicology

SN - 0260-437X

IS - 5

ER -